Our story:
Ontario welcomes JLABS
JLABS @ TorontoMaRS Centre, West Tower
661 University Avenue, Suite 1300
Toronto, Ontario, Canada
M5G 0B7
647-243-5200
Get directions
As the first JLABS to open outside the United States, JLABS @ Toronto joins a network of life science facilities that are based throughout the United States in San Diego (the flagship JLABS), San Francisco, Boston and Houston.
These facilities are home to over 140 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs. JLABS @ Toronto is located on the 13th floor in the MaRS West Tower and is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. JLABS @ Toronto opened on May 11th, 2016, the 40,000-square foot facility includes cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts.
The space also features JLABS' inaugural device and digital prototype lab that provides entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.
Our Residents
45 Resident Companies
See all companiesSo far, the JLABS experience has been incredible; really a game-changer for Immune Biosolutions!
The more direct benefit and the most valuable one that we received for being a JLABS resident company is access to a world class network of investors and industry partners.
JLABS provides unprecedented access to industry leadership within the context of an agile and innovative atmosphere that is essential for startups to grow.
As a startup you need to move beyond your core technical expertise and balance that with running a business. JLABS has helped with that balance by providing us access to expertise and technology that bring our ideas to life.
Impact
Bringing expertise to Canada
209+
Meetings
Facilitated for JLABS companies or external Canadian healthcare companies with an investor.
- Lyon Wong, Co-founder & General Partner, Spectrum 28
11
Investors taking part in JLABS Investor Hub
Activation Impact across Canada
80+
Events hosted
6,950+
Attendees
60+
J&J INNOVATION ENGAGEMENTS
across Canada since 2016
320+
Internal JNJ Expert Days
(Directors & VPs travelled globally to provide mentorship to our JLABS Companies)
I really enjoyed the opportunity itself to apply and meet with investors I wouldn’t otherwise have access to, like AbbVie Ventures today. Please keep up the good work! And schedule more VC's for 2017.
Just a note of sincere thanks. The quality of the speaker and the content was timely, relevant and useable information, also the JLABS space & organization of the event was impressive. My thanks for the time they put into these events.
I felt all of the speakers were incredibly prepared and I got a lot out of the experience in general. The speakers were approachable after the event and offered practical advice to our questions. The event was thoughtfully structured and it was great to have so many interesting people in the room.
News
Photos
- Dawn Bell - Chief Scientific Officer and Vice-President, Scientific Affairs, Novartis Pharmaceuticals Canada Inc.